Sphingosine-1-phosphate reduces hepatic ischaemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice

Nephrology

Volumn 16, Issue 2, 2011, Pages 163-173

  Lee, So Young ^a   Kim, Dong Hee ^a   Sung, Su Ah ^a   Kim, Myung Gyu ^b   Cho, Won Yong ^b   Kim, Hyoung Kyu ^b   Jo, Sang Kyung ^b  

^a Eulji University Hospital   (Japan)

^b Korea University Ansan Hospital   (South Korea)

Author keywords

acute kidney injury; endothelial dysfunction; hepatic ischaemia reperfusion injury; sphingosine 1 phosphate

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; ALANINE AMINOTRANSFERASE; CREATININE; CYTOKINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SPHINGOSINE 1 PHOSPHATE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIUM INJURY; HISTOLOGY; KIDNEY; KIDNEY INJURY; LEUKOCYTE; LIVER ISCHEMIA; LIVER PROTECTION; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; CAPILLARY PERMEABILITY; CHEMOKINE CCL2; CREATININE; ENDOTHELIUM; INFLAMMATION; INTERLEUKIN-6; LIPOCALINS; LIVER; LYSOPHOSPHOLIPIDS; MICE; MODELS, ANIMAL; ONCOGENE PROTEINS; RECEPTORS, LYSOSPHINGOLIPID; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551569626     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01386.x     Document Type: Article

References (48)

1. Gainza FJ, Valdivieso A, Quintanilla N, et al. Evaluation of acute renal failure in the liver transplantation perioperative period: incidence and impact. Transplant. Proc. 2002; 34: 250-51.
2. Pawarode A, Fine DM, Thuluvath PJ,. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl. 2003; 9: 741-7.
3. Hsu YC, Chou TY, Chen CF, Wang D, Su CL, Hu RT,. Rat liver ischemia/reperfusion induced proinflammatory mediator and antioxidant expression analyzed by gene chips and real-time polymerase chain reactions. Transplant. Proc. 2008; 40: 2156-8.
4. Davis CL, Gonwa TA, Wilkinson AH,. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl. 2002; 8: 91-109.
5. Wadei HM, Mai ML, Ahsan N, Gonwa TA,. Hepatorenal syndrome: pathophysiology and management. Clin. J. Am. Soc. Nephrol. 2006; 1: 1066-79.
6. Walsh KB, Toledo AH, Rivera- Chavez FA, Lopez-Neblina F, Toledo-Pereyra LH,. Inflammatory mediators of liver ischemia-reperfusion injury. Exp. Clin. Transplant. 2009; 7: 78-93.
7. Nakano Y, Kondo T, Matsuo R, et al. Platelet dynamics in the early phase of postischemic liver in vivo. J. Surg. Res. 2007; 15: 15.
8. Kondo T, Todooki T, Hirano T, Schildberg FW, Messmer K,. Impact of ischemia-reperfusion injury on dimensional changes of hepatic microvessels. Res. Exp. Med. (Berl). 1998; 198: 63.
9. Lee HT, Park SW, Kim M, D'Agati VD,. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab. Invest. 2009; 89: 196-208.
10. Sheridan AM, Bonventre JV,. Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr. Opin. Nephrol. Hypertens. 2000; 9: 427-34.
11. Sutton TA, Fisher CJ, Molitoris BA,. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002; 62: 1539-49.
12. Sutton TA, Mang H, Campos SB, Sandoval R, Yoder M, Molitoris BA,. Injury of the renal microvascular endothelium alters barrier function following ischemia. Am. J. Physiol. Renal. Physiol. 2003; 285: F191-F198.
13. Hla T, Lee MJ, Ancellin N, et al. Sphingosine-1-phosphate: extracellular second messenger? Biochem. Pharmacol. 1999; 58: 201-7.
14. Igarashi Y, Yatomi Y,. Sphingosine-1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles. Acta. Biochim. Pol. 1998; 45: 299-309.
15. Moolenaar WH,. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 1999; 253: 230-38.
16. Spiegel S,. Sphingosine-1-phosphate: a prototype of a new class of second messengers. J. Leukoc. Biol. 1999; 65: 341-4.
17. An S, Goetzl EJ, Lee H,. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and Sphingosine-1-phosphate. J. Cell. Biochem. Suppl. 1998; 30-31: 147-57.
18. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998; 79: 1552-5.
19. Zondag GC, Postma FR, Etten IV, Verlaan I, Moolenaar WH,. Sphingosine-1-phosphate signaling through the G-protein-coupled receptor Edg-1. Biochem. J. 1998; 330: 605-9.
20. Awad AS, Ye H, Huang L, et al. Selective sphingosine-1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am. J. Physiol. Renal. Physiol. 2006; 290: F1516-24.
21. Garcia JG, Liu F, Verin AD, et al. Sphingosine-1-phosphate promotes endothelial barrier integirity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 2001; 108: 689-701.
22. Schaphorst KL, Chiang E, Jacobs KN, et al. Role of Sphingosine-1- phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 285: L258-L267.
23. Liu Y, Wada R, Yamashita T, et al. Edg-1, the G-protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Ciln. Invest. 2000; 106: 951-61.
24. 3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc. Natl. Acad. Sci. USA 2005; 102: 9270-75.
25. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J,. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD 1d-dependent NKT cell activation. J. Exp. Med. 2006; 203: 2639-48.
26. Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J,. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286: G285-G293.
27. Parikh CR, Jani A, Mishera J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am. J. Transplant. 2006; 6: 1639-45.
28. Davis MD, Clemens JJ, Macdonald TL, Lynch KR,. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 2005; 280: 9883-41.
29. Nicholson DW, Ali A, Thomberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosios. Nature 1995; 376: 17-18.
30. Standiford TJ, Kunkel ST, Lukacs NW, et al. Macrophage inflammatory protein-1α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 1995; 155: 1515-24.
31. Padanilam BJ, Martin DR, Hammerman MR,. Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 1996; 137: 2133-40.
32. Behrends M, Hirose R, Park YH, et al. Remote renal injury following partial hepatic ischemia/reperfusion injury in rats. J. Gastrointest. Surg. 2008; 12: 490-95.
33. Weinbroum AA, Hochhauser E, Rudick V, et al. Direct induction of acute lung and myocardial dysfunction by liver ischemia and reperfusion. J. Trauma 1997; 43: 627-33.
34. Velidedeoglu E, Bloom RD, Crawford MD, et al. Early kidney dysfunction post liver transplant predicts late chronic kidney disease. Transplantation 2004; 77: 553-6.
35. Park SW, Kim M, Chen SWC, D'Agati VD, Lee HT,. Shinganine 1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock 2010; 33 (1): 31-42.
36. Hellberg PO, Kallskog OT, Ojtec G, Wolgast M,. Peritubular capillary permeability and intravascular RBC aggregation after ischemia: effects of neutrophils. Am. J. Physiol. 1990; 258: F1018-25.
37. Brodsky SV, Yammamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am. J. Physiol. Renal. Physiol. 2002; 282: F1140-49.
38. Yamamoto T, Tada T, Brodsky SV, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am. J. Physiol. Renal. Physiol. 2002; 282: F1150-55.
39. McDonagh PF,. Platelets reduce coronary microvascular permeability to macromolecules. Am. J. Physiol. 1986; 251: H581-7.
40. Gimbrone MA Jr, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J,. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 1969; 221 (188): 33-6.
41. Rouschop KMA, Roelofs JJTH, Claessen N, et al. Protection against renal ischemia reperfusion injury by CD 44 disruption. J. Am. Soc. Nephrol. 2005; 16: 2034-43.
42. Lewington AJP, Padanilam BJ, Martin DR, Hammerman MR,. Expression of CD 44 in kidney after acute ischemic injury in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000; 278: R247-R254.
43. Siew ED, Ware LB, Gebretsadik T, et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J. Am. Soc. Nephrol. 2009; 20: 1823-32.
44. Bolick DT, Srinivasan S, Kim KW, et al. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 976-81.
45. Paik JH, Chae SS, Lee MJ, Thangada S, Hla T,. Sphingosine-1-phosphate- induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha beta3- and beta1-containing integrins. J. Biol. Chem. 2001; 276: 11830-37.
46. Kimura T, Watanabe T, Sato K, et al. Sphingosine-1-phosphate stimulates proliferation and migration of human endothelial cells possibly though the lipid receptors, Edg-1 and Edg-3. Biochem. J. 2000; 348: 71-6.
47. Sanna MG, Liao J, Jo E, et al. Sphingosine-1-phosphate(S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 2004; 279: 13839-48.
48. 3 transactivation. Am. J. Respir. Cell Mol. Biol. 2007; 37: 222-31.